ARCHIVE

• Takeda, Beth Israel Deaconess Medical Center to Collaborate on Metabolic Disease Research
  January 27, 2003

• Dipyridamole Shows Lowest Bleeding Risk in Secondary Stroke Prevention
  January 27, 2003

• Sales of Cancer Analgesic Durotep Patch Rising Fast: Janssen, Kyowa Hakko
  January 27, 2003

• Takara Bio Strengthens Collaboration with Lynx Therapeutics
  January 27, 2003

• Boehringer Ingelheim to Codevelop Anticancer Agents with Sagres Discovery
  January 27, 2003

• GE Makers Must Be Self-reliant: EPMA President Sugiura
  January 27, 2003

• RESEARCH & DEVELOPMENT NEWS IN BRIEF
  January 27, 2003

• Chugai, GSK, Novartis to Enhance Supply of Drugs for Influenza
  January 27, 2003

• BUSINESS NEWS IN BRIEF
  January 27, 2003

• Kyorin, Taisho: Switch OTC Versions of Amorolfine for Athlete's Foot
  January 27, 2003

• Eisai, Mitsui Knowledge to Collaborate in Bioinformatics Field
  January 27, 2003

• Gov't Urged to Take Further Action to Promote Self-medication
  January 27, 2003

• Sales of Sumitomo's Antipsychotic Lullan Likely to Miss Target
  January 27, 2003

• Married Women Aged 60 or Older Most Confident about Their Health
  January 27, 2003

• Leaders Determined to Tackle Problems in 2003: New Year Addresses
  January 20, 2003

• Making 2003 "Epoch-making Year" for Self-medication: OTC Direct Selling Maker Leaders
  January 20, 2003

• Rapid Response to Market Changes Crucial: Mr Matsutani of Toho
  January 20, 2003

• Ain Pharmaciez: Operating Profits Up 44%
  January 20, 2003

• JPMA Aims for NHI Prices in Line with Value
  January 20, 2003

• Kobayashi Pharm Creates 100%-owned Subsidiary in China
  January 20, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 624
• 625
• 626
• 627
• 628
• 629
• 630
• 631
• 632
• …
• Next ›
• 最終 »